Details for New Drug Application (NDA): 202764
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 202764
Tradename: | GABAPENTIN |
Applicant: | Invagen Pharms |
Ingredient: | gabapentin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202764
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 202764
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GABAPENTIN | gabapentin | TABLET;ORAL | 202764 | ANDA | Proficient Rx LP | 63187-149 | 63187-149-30 | 30 TABLET in 1 BOTTLE (63187-149-30) |
GABAPENTIN | gabapentin | TABLET;ORAL | 202764 | ANDA | Proficient Rx LP | 63187-149 | 63187-149-60 | 60 TABLET in 1 BOTTLE (63187-149-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Oct 16, 2012 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | Oct 16, 2012 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription